BCL2A1 and ovarian cancer: By quantifying the band intensities of BCL2A1, we noted a 2.7-fold increase in BCL2A1 in metastatic ovarian cancer cells isolated from lavage/ascites compared with those isolated from primary ovarian tumors (Figure 3F).